Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world perioperative butorphanol study in elective lower abdominal cancer surgery
ChiCTR2000032588Phase 4Not yet recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of butorphanol in perioperative pain and perioperative sedation, sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: VAS pain score, Ramsay Sedation score and 2 more. Planned start May 2020; status: not yet recruiting.
02
Drugs
butorphanol
03
Conditions
perioperative painperioperative sedation
Beyond the preview
Go deeper on ChiCTR2000032588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032588.